Literature DB >> 22837529

Membrane damage and repair in primary monocytes exposed to human β-defensin-3.

Anthony B Lioi1, Angel L Reyes Rodriguez, Nicholas T Funderburg, Zhimin Feng, Aaron Weinberg, Scott F Sieg.   

Abstract

Interactions of AMPs with plasma membranes of primary human immune cells are poorly characterized. Analysis of PI exclusion as a measure of membrane integrity indicated that hBD-3 caused membrane perturbations in monocytes but not T or B cells at concentrations typically used to kill bacteria or to induce activation of APCs. Bleb-like structures were observed in monocytes exposed to hBD-3. These cells also increased surface expression of LAMP1, a membrane repair marker after exposure to hBD-3. Furthermore, cell death was enhanced by adding an inhibitor of membrane repair. Removal of cholesterol from membranes resulted in greater susceptibility of cells to hBD-3, but cholesterol content was not different between the cell types, as assessed by filipin staining. Freshly isolated monocytes expressed higher levels of the negatively charged phospholipid, PS, on their outer leaflet compared with B or T cells. Preincubation of monocytes with molecules that bind PS protected these cells from hBD-3-induced membrane damage, suggesting that outer-membrane PS expression can at least partially explain monocyte susceptibility to hBD-3. The potential for membrane disruption caused by AMPs should be evaluated in various cell types when considering these molecules for therapeutic applications in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22837529      PMCID: PMC4050522          DOI: 10.1189/jlb.0112046

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  30 in total

1.  Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand Annexin V to dying but not viable cells and implications for PS-dependent clearance.

Authors:  U Appelt; A Sheriff; U S Gaipl; J R Kalden; R E Voll; M Herrmann
Journal:  Cell Death Differ       Date:  2005-02       Impact factor: 15.828

2.  Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines.

Authors:  François Niyonsaba; Hiroko Ushio; Nobuhiro Nakano; William Ng; Koji Sayama; Koji Hashimoto; Isao Nagaoka; Ko Okumura; Hideoki Ogawa
Journal:  J Invest Dermatol       Date:  2006-10-19       Impact factor: 8.551

3.  Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2.

Authors:  Johann Röhrl; De Yang; Joost J Oppenheim; Thomas Hehlgans
Journal:  J Immunol       Date:  2010-05-17       Impact factor: 5.422

4.  Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.

Authors:  Lingling Sun; Catherine M Finnegan; Tina Kish-Catalone; Robert Blumenthal; Paolo Garzino-Demo; Gian M La Terra Maggiore; Sid Berrone; Carol Kleinman; Zhibin Wu; Sayed Abdelwahab; Wuyuan Lu; Alfredo Garzino-Demo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.

Authors:  D Yang; O Chertov; S N Bykovskaia; Q Chen; M J Buffo; J Shogan; M Anderson; J M Schröder; J M Wang; O M Howard; J J Oppenheim
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

Review 6.  Human beta-defensins.

Authors:  M Pazgier; D M Hoover; D Yang; W Lu; J Lubkowski
Journal:  Cell Mol Life Sci       Date:  2006-06       Impact factor: 9.261

7.  Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death.

Authors:  Jialan Shi; Yinan Shi; Lasse N Waehrens; Jan T Rasmussen; Christian W Heegaard; Gary E Gilbert
Journal:  Cytometry A       Date:  2006-12-01       Impact factor: 4.355

8.  Antimicrobial peptides human beta-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability.

Authors:  Xuejun Chen; François Niyonsaba; Hiroko Ushio; Mutsuko Hara; Hidenori Yokoi; Kenji Matsumoto; Hirohisa Saito; Isao Nagaoka; Shigaku Ikeda; Ko Okumura; Hideoki Ogawa
Journal:  Eur J Immunol       Date:  2007-02       Impact factor: 5.532

9.  An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.

Authors:  Ge Jin; Hameem I Kawsar; Stanley A Hirsch; Chun Zeng; Xun Jia; Zhimin Feng; Santosh K Ghosh; Qing Yin Zheng; Aimin Zhou; Thomas M McIntyre; Aaron Weinberg
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

10.  Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2.

Authors:  Nicholas Funderburg; Michael M Lederman; Zhimin Feng; Michael G Drage; Julie Jadlowsky; Clifford V Harding; Aaron Weinberg; Scott F Sieg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-15       Impact factor: 11.205

View more
  10 in total

1.  Human β defensin-3 induces chemokines from monocytes and macrophages: diminished activity in cells from HIV-infected persons.

Authors:  Velizar Petrov; Nicholas Funderburg; Aaron Weinberg; Scott Sieg
Journal:  Immunology       Date:  2013-12       Impact factor: 7.397

Review 2.  Immunomodulatory and Allergenic Properties of Antimicrobial Peptides.

Authors:  Svetlana V Guryanova; Tatiana V Ovchinnikova
Journal:  Int J Mol Sci       Date:  2022-02-24       Impact factor: 5.923

3.  Cytotoxicity of HBD3 for dendritic cells, normal human epidermal keratinocytes, hTERT keratinocytes, and primary oral gingival epithelial keratinocytes in cell culture conditions.

Authors:  Nattawut Leelakanok; Carol L Fischer; Amber M Bates; Janet M Guthmiller; Georgia K Johnson; Aliasger K Salem; Kim A Brogden; Nicole K Brogden
Journal:  Toxicol Lett       Date:  2015-09-11       Impact factor: 4.372

4.  Human β Defensin-3 Increases CD86 Expression on Monocytes by Activating the ATP-Gated Channel P2X7.

Authors:  Anthony B Lioi; Brian M Ferrari; George R Dubyak; Aaron Weinberg; Scott F Sieg
Journal:  J Immunol       Date:  2015-09-28       Impact factor: 5.422

5.  Ca2+ -regulated lysosome fusion mediates angiotensin II-induced lipid raft clustering in mesenteric endothelial cells.

Authors:  Wei-Qing Han; Wen-Dong Chen; Ke Zhang; Jian-Jun Liu; Yong-Jie Wu; Ping-Jin Gao
Journal:  Hypertens Res       Date:  2016-01-14       Impact factor: 3.872

6.  Citrus bergamia Juice Extract Attenuates β-Amyloid-Induced Pro-Inflammatory Activation of THP-1 Cells Through MAPK and AP-1 Pathways.

Authors:  Monica Currò; Roberto Risitano; Nadia Ferlazzo; Santa Cirmi; Chiara Gangemi; Daniela Caccamo; Riccardo Ientile; Michele Navarra
Journal:  Sci Rep       Date:  2016-02-08       Impact factor: 4.379

Review 7.  Guardians of the Gut: Enteric Defensins.

Authors:  Sumathi Sankaran-Walters; Ronald Hart; Chantelle Dills
Journal:  Front Microbiol       Date:  2017-04-19       Impact factor: 5.640

Review 8.  The Dichotomous Responses Driven by β-Defensins.

Authors:  Jennifer R Shelley; Donald J Davidson; Julia R Dorin
Journal:  Front Immunol       Date:  2020-06-12       Impact factor: 7.561

9.  Molecular Dynamics Simulations of Human Beta-Defensin Type 3 Crossing Different Lipid Bilayers.

Authors:  Rabeta Yeasmin; Ann Brewer; Lela R Fine; Liqun Zhang
Journal:  ACS Omega       Date:  2021-05-18

10.  Human β-defensin 3 contains an oncolytic motif that binds PI(4,5)P2 to mediate tumour cell permeabilisation.

Authors:  Thanh Kha Phan; Fung T Lay; Ivan K H Poon; Mark G Hinds; Marc Kvansakul; Mark D Hulett
Journal:  Oncotarget       Date:  2016-01-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.